InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
68,594.83
(
0.09%
)
Post# of 251938
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119690
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Wednesday, 12/20/2006 3:37:05 PM

Wednesday, December 20, 2006 3:37:05 PM

Post# of 251938
Dawson James Securities Initiates Research Coverage on Viragen

[Stephen Dunn from Dawson James is the “analyst” who pumped GENR in a report when GENR traded at 5x today’s price. That report was used by the moderator of a GENR message board to suck in unsophisticated investors. I noted at the time that Mr. Dawson was either a paid shill or a charlatan because he claimed that GENR was running a trial that would show Evizon was non-inferior to Avastin and Lucentis in spite of the fact that neither Avastin nor Lucentis was used in the trial. Caveat emptor!]

http://biz.yahoo.com/prnews/061220/clw081.html?.v=40

>>
Wednesday December 20, 10:48 am ET

PLANTATION, Fla., Dec. 20 /PRNewswire-FirstCall/ -- Viragen, Inc. (Amex: VRA ; VRA.U; VRA.WS) today announced that Dawson James Securities' Director of Research, Stephen M. Dunn, initiated research coverage with a "Speculative Buy" rating.

...The Dawson James research report was prepared by Dawson James Securities, Inc. and the opinions, recommendations, estimates and/or forecasts contained in the report are those of Dawson James Securities, Inc. and not necessarily those of Viragen. The reference to the Dawson James research report does not signify Viragen's endorsement or adoption of the report or its concurrence with the information contained therein. Viragen assumes no responsibility for the accuracy or adequacy of the report, or any obligation to comment upon or update the report should all or any portion of the report be or become inaccurate.
<<

LMAO

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up